188 related articles for article (PubMed ID: 30134812)
1. Enrichment of B cell receptor signaling and epidermal growth factor receptor pathways in monoclonal gammopathy of undetermined significance: a genome-wide genetic interaction study.
Chattopadhyay S; Thomsen H; da Silva Filho MI; Weinhold N; Hoffmann P; Nöthen MM; Marina A; Jöckel KH; Schmidt B; Pechlivanis S; Langer C; Goldschmidt H; Hemminki K; Försti A
Mol Med; 2018 Jun; 24(1):30. PubMed ID: 30134812
[TBL] [Abstract][Full Text] [Related]
2. Genomewide association study on monoclonal gammopathy of unknown significance (MGUS).
Thomsen H; Campo C; Weinhold N; da Silva Filho MI; Pour L; Gregora E; Vodicka P; Vodickova L; Hoffmann P; Nöthen MM; Jöckel KH; Langer C; Hajek R; Goldschmidt H; Hemminki K; Försti A
Eur J Haematol; 2017 Jul; 99(1):70-79. PubMed ID: 28375557
[TBL] [Abstract][Full Text] [Related]
3. Coinherited genetics of multiple myeloma and its precursor, monoclonal gammopathy of undetermined significance.
Clay-Gilmour AI; Hildebrandt MAT; Brown EE; Hofmann JN; Spinelli JJ; Giles GG; Cozen W; Bhatti P; Wu X; Waller RG; Belachew AA; Robinson DP; Norman AD; Sinnwell JP; Berndt SI; Rajkumar SV; Kumar SK; Chanock SJ; Machiela MJ; Milne RL; Slager SL; Camp NJ; Ziv E; Vachon CM
Blood Adv; 2020 Jun; 4(12):2789-2797. PubMed ID: 32569378
[TBL] [Abstract][Full Text] [Related]
4. Inherited genetic susceptibility to monoclonal gammopathy of unknown significance.
Weinhold N; Johnson DC; Rawstron AC; Försti A; Doughty C; Vijayakrishnan J; Broderick P; Dahir NB; Begum DB; Hosking FJ; Yong K; Walker BA; Hoffmann P; Mühleisen TW; Langer C; Dörner E; Jöckel KH; Eisele L; Nöthen MM; Hose D; Davies FE; Goldschmidt H; Morgan GJ; Hemminki K; Houlston RS
Blood; 2014 Apr; 123(16):2513-7; quiz 2593. PubMed ID: 24449210
[TBL] [Abstract][Full Text] [Related]
5. Familial monoclonal gammopathy of undetermined significance and multiple myeloma: epidemiology, risk factors, and biological characteristics.
Greenberg AJ; Rajkumar SV; Vachon CM
Blood; 2012 Jun; 119(23):5359-66. PubMed ID: 22354002
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal Gammopathy of Undetermined Significance (MGUS)Monoclonal Gammopathy of Undetermined Significance (MGUS).
Viera S; Ludek P; Zdeněk A; Marta K; Martin Š; Sabina Š; Zdeněk K
Klin Onkol; 2018; 31(4):270-276. PubMed ID: 30541309
[TBL] [Abstract][Full Text] [Related]
7. Genomewide profiling of copy-number alteration in monoclonal gammopathy of undetermined significance.
Mikulasova A; Smetana J; Wayhelova M; Janyskova H; Sandecka V; Kufova Z; Almasi M; Jarkovsky J; Gregora E; Kessler P; Wrobel M; Walker BA; Wardell CP; Morgan GJ; Hajek R; Kuglik P
Eur J Haematol; 2016 Dec; 97(6):568-575. PubMed ID: 27157252
[TBL] [Abstract][Full Text] [Related]
8. Clues to pathogenesis of Waldenström macroglobulinemia and immunoglobulin M monoclonal gammopathy of undetermined significance provided by analysis of immunoglobulin heavy chain gene rearrangement and clustering of B-cell receptors.
Varettoni M; Zibellini S; Capello D; Arcaini L; Rossi D; Pascutto C; Rattotti S; Mangiacavalli S; Pochintesta L; Gotti M; Gaidano G; Cazzola M
Leuk Lymphoma; 2013 Nov; 54(11):2485-9. PubMed ID: 23442064
[TBL] [Abstract][Full Text] [Related]
9. A genetic risk score of alleles related to MGUS interacts with socioeconomic position in a population-based cohort.
Baak L; Frank M; Dürig J; Dührsen U; Hoffmann P; Nöthen MM; Dragano N; Erbel R; Jöckel KH; Schmidt B
Sci Rep; 2022 Mar; 12(1):4409. PubMed ID: 35292679
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal Gammopathy of Undetermined Significance: A Comprehensive Review.
Kaur J; Valisekka SS; Hameed M; Bandi PS; Varma S; Onwughalu CJ; Ibrahim H; Mongia H
Clin Lymphoma Myeloma Leuk; 2023 May; 23(5):e195-e212. PubMed ID: 36966041
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Genes and Molecular Pathways Involved in the Progression of Monoclonal Gammopathy of Undetermined Significance (MGUS) to Multiple Myeloma: A Systems Biology Approach.
Khalili P; Maddah R; Maleknia M; Shateri Amiri B; Forouzani F; Hasanvand A; Rezaeeyan H
Mol Biotechnol; 2023 Aug; 65(8):1275-1286. PubMed ID: 36504354
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide genetic analyses highlight mitogen-activated protein kinase (MAPK) signaling in the pathogenesis of endometriosis.
Uimari O; Rahmioglu N; Nyholt DR; Vincent K; Missmer SA; Becker C; Morris AP; Montgomery GW; Zondervan KT
Hum Reprod; 2017 Apr; 32(4):780-793. PubMed ID: 28333195
[TBL] [Abstract][Full Text] [Related]
13. Pathway-based network analysis of myeloma tumors: monoclonal gammopathy of unknown significance, smoldering multiple myeloma, and multiple myeloma.
Dong L; Chen CY; Ning B; Xu DL; Gao JH; Wang LL; Yan SY; Cheng S
Genet Mol Res; 2015 Aug; 14(3):9571-84. PubMed ID: 26345890
[TBL] [Abstract][Full Text] [Related]
14. Untangling fracture risk in monoclonal gammopathy of undetermined significance: A population-based cohort study.
Rögnvaldsson S; Aspelund T; Thorsteinsdóttir S; Turesson I; Björkholm M; Landgren O; Kristinsson SY
Eur J Haematol; 2021 Jul; 107(1):137-144. PubMed ID: 33840154
[TBL] [Abstract][Full Text] [Related]
15. Autoimmune disease is associated with a lower risk of progression in monoclonal gammopathy of undetermined significance.
Baldursdóttir TR; Löve ÞJ; Gíslason GK; Björkholm M; Mellqvist UH; Lund SH; Blimark CH; Turesson I; Hultcrantz M; Landgren O; Kristinsson SY
Eur J Haematol; 2021 Mar; 106(3):380-388. PubMed ID: 33295006
[TBL] [Abstract][Full Text] [Related]
16. Association of a dominantly inherited hyperphosphorylated paraprotein target with sporadic and familial multiple myeloma and monoclonal gammopathy of undetermined significance: a case-control study.
Grass S; Preuss KD; Ahlgrimm M; Fadle N; Regitz E; Pfoehler C; Murawski N; Pfreundschuh M
Lancet Oncol; 2009 Oct; 10(10):950-6. PubMed ID: 19767238
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal Gammopathy of Undetermined Significance: Current Concepts and Future Prospects.
Seth S; Zanwar S; Vu L; Kapoor P
Curr Hematol Malig Rep; 2020 Apr; 15(2):45-55. PubMed ID: 32222885
[TBL] [Abstract][Full Text] [Related]
18. Incidence and evolution of monoclonal gammopathy of undetermined significance (MGUS) in Greece.
Anagnostopoulos A; Evangelopoulou A; Sotou D; Gika D; Mitsibounas D; Dimopoulos MA
Ann Hematol; 2002 Jul; 81(7):357-61. PubMed ID: 12185503
[TBL] [Abstract][Full Text] [Related]
19. Prior autoimmune disease and risk of monoclonal gammopathy of undetermined significance and multiple myeloma: a systematic review.
McShane CM; Murray LJ; Landgren O; O'Rorke MA; Korde N; Kunzmann AT; Ismail MR; Anderson LA
Cancer Epidemiol Biomarkers Prev; 2014 Feb; 23(2):332-42. PubMed ID: 24451437
[TBL] [Abstract][Full Text] [Related]
20. Quantitative polymerase Chain reaction profiling of microRNAs in peripheral lymph-monocytes from MGUS subjects.
Avenoso A; Campo S; Scuruchi M; Mania M; Innao V; D'Ascola A; Mandraffino G; Allegra AG; Musolino C; Allegra A
Pathol Res Pract; 2021 Feb; 218():153317. PubMed ID: 33360970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
